Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1Leukemia 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 33fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 17Whole-Body Irradiation 15Etoposide 15Rituximab 14Tacrolimus 13Busulfan 12Vincristine 11Prednisone 11Methotrexate 11Filgrastim 11Doxorubicin 11Cyclosporine 11Radiotherapy 10Brentuximab Vedotin 10Antilymphocyte Serum 10Methylprednisolone 8Cytarabine 8Melphalan 7Cisplatin 6Ifosfamide 5Gemcitabine 5merphos 4ibritumomab tiuxetan 4Sirolimus 4Flow Cytometry 4Dexamethasone 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Anaplastic × Radioimmunotherapy × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡